Teva Pharmaceutical Industries (TEVA) EBITDA Margin (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) reported EBITDA Margin of 0.24% for Q2 2026, down 16.66 percentage points from 16.91% a year earlier and down 22.13 percentage points from the prior quarter.
Teva Pharmaceutical Industries (TEVA) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Teva Pharmaceutical Industries' EBITDA Margin came in at 14.97%, up 3.44 percentage points year-over-year; for FY2025, it came in at 18.30%, up 13.73 percentage points from FY2024.
- EBITDA Margin has a five-year change of +30.40 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 4.57% in FY2024 (-5.44 pp), 10.01% in FY2023 (+15.97 pp), -5.96% in FY2022 (-25.14 pp) and 19.18% in FY2021 (+31.28 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBITDA Margin since Q2 2023.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of +1.63 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q3 2021 (a gain of 124.06 percentage points); the low point was Q2 2022 (a drop of 38.77 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 22.38% (Q1 2026), 11.89% (Q4 2025) and 25.25% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 0.24% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.24% |
| Mar 31, 2026 | 22.38% |
| Dec 31, 2025 | 11.89% |
| Sep 30, 2025 | 25.25% |
| Jun 30, 2025 | 16.91% |
| Mar 31, 2025 | 19.61% |
| Dec 31, 2024 | 5.68% |
| Sep 30, 2024 | 4.80% |
| Jun 30, 2024 | 6.10% |
| Mar 31, 2024 | 1.41% |
| Dec 31, 2023 | 22.93% |
| Sep 30, 2023 | 16.29% |
| Jun 30, 2023 | -9.13% |
| Mar 31, 2023 | 7.95% |
| Dec 31, 2022 | -16.32% |
| Sep 30, 2022 | 20.72% |
| Jun 30, 2022 | -16.09% |
| Mar 31, 2022 | -10.65% |
| Dec 31, 2021 | 9.71% |
| Sep 30, 2021 | 24.49% |
Teva Pharmaceutical Industries EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();